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Quadruple-Drug Induction Therapy in 
Highly Sensitized Patients 
W-D. Miner, S. Schleibner, D. Abendroth, and W. Land 
THE I M M U N O L O G I C prognosis of a renal allograft correlates—at least in 
part—with the state of preformed cytotoxic 
antibodies of the recipient. Patients with reac­
tivity against more than 50% of the test panel 
had an inferior graft outcome compared with 
patients with fewer or no antibodies.1,2 To 
demonstrate a beneficial effect of quadruple-
drug induction therapy in highly sensitized 
patients we treated 40 presensitized recipients 
with an immunosuppressive protocol consist­
ing of low-dose cyclosporine (CyA), azathio­
prine, antilymphocyte/antithymocyte globu­
lin ( A L G / A T G ) , and high-dose steroids for a 
short period of time. In this study group we 
expected a reduced nephrotoxic side effect of 
CyA, a satisfied immunosuppressive index, 
and an acceptable complication rate. Parts of 
this study have already been published else­
where.3 
P A T I E N T S A N D M E T H O D S 
From August 1985 to August 1987 we performed 40 
cadaveric kidney transplantations in highly sensitized 
patients. The latest mean level of preformed lymphocyto-
toxic antibodies was 65% (minimum, 30%; maximum, 
98%). Seventeen of these patients received a first graft, 17 
patients received a second transplant, four patients 
received a third graft, and two patients received a fourth 
transplant. Most of the recipients received a well-
matched graft. The mean mismatch at the H L A - A locus 
was 1.1; at the H L A - B locus, 1.2; and at the H L A - D R 
locus, 0.6. 
The immunosuppressive protocol (induction phase) 
consisted of CyA starting at 6 mg/kg body weight orally, 
and later increased to achieve whole blood target CyA 
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trough levels between 300 and 500 ng/mL, azathioprine 
at 1 to 2 mg/kg body weight for 3 weeks, A T G / A L G at 4 
mg/kg body weight for seven days, and methylpredniso-
lone at 500 mg/d tapered to 30 mg/d within 1 week. 
R E S U L T S 
The 2-year graft survival probability (Cut-
ler/Ederer formula4) in this study group is 
72% (Fig 1). No patient died during the 
follow-up period from August 1985 to August 
1987. The infection rate of 15% is low. The 
myelodepressive effect in 22% was reversed in 
all patients after withdrawing azathioprine 
therapy. Acute nephrotoxicity was observed in 
only three patients. 
C O N C L U S I O N 
Quadruple-drug induction therapy im­
proves kidney graft survival in highly sensi­
tized patients. This immunosuppressive proto­
col is a safe approach because the infectious 
complications are low and the early nephro­
toxic side effect of CyA is greatly reduced. 
The frequency of rejection episodes (55%) is 
increased, and this is the point of great inter­
est—most of them are associated with CyA 
trough values smaller than 200 ng/mL within 
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Fig 1. Survival in highly sensit ized pat ients. T w o -
year graft survival probability ( C u t l e r / E d e r e r formula) 
in this study group from August 1985 to August 1987 . 
• , Graft survival; — , patient survival . 
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Fig 2 . Reject ion episodes related to C y A trough blood levels in sensit ized patients, η = 40 . 
under antirejection treatment might suggest 
that the starting dose of CyA (6 mg/kg body 
weight orally) was not sufficient and should 
be corrected to get CyA trough levels above 
this value, at least in this category of 
patients. 
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